APA (7th ed.) Citation

Ragni, M. V., Novelli, E. M., Murshed, A., Merricks, E. P., Kloos, M. T., & Nichols, T. C. (2013). Phase II prospective open-label trial of recombinant interleukin-11 in desmopressin-unresponsive von Willebrand disease and mild or moderate haemophilia A. Thrombosis and haemostasis, 109(2), 248. https://doi.org/10.1160/TH12-06-0447

Chicago Style (17th ed.) Citation

Ragni, Margaret V., Enrico M. Novelli, Anila Murshed, Elizabeth P. Merricks, Mark T. Kloos, and Timothy C. Nichols. "Phase II Prospective Open-label Trial of Recombinant Interleukin-11 in Desmopressin-unresponsive Von Willebrand Disease and Mild or Moderate Haemophilia A." Thrombosis and Haemostasis 109, no. 2 (2013): 248. https://doi.org/10.1160/TH12-06-0447.

MLA (9th ed.) Citation

Ragni, Margaret V., et al. "Phase II Prospective Open-label Trial of Recombinant Interleukin-11 in Desmopressin-unresponsive Von Willebrand Disease and Mild or Moderate Haemophilia A." Thrombosis and Haemostasis, vol. 109, no. 2, 2013, p. 248, https://doi.org/10.1160/TH12-06-0447.